TRAVERE THERAPEUTICS INC (TVTX) Institutional Ownership Changes & 13F Activity

TRAVERE THERAPEUTICS INC (TVTX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC and Viking Global Investors.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026Renaissance Technologies LLCSell-280,0001,966,779$58,433,004
Q4 2025Renaissance Technologies LLCBuy494,6652,246,779$85,849,426
Q3 2025Renaissance Technologies LLCSell-743,0001,752,114$41,875,525
Q2 2025Renaissance Technologies LLCSell-207,7002,495,114$36,927,687
Q1 2025Viking Global InvestorsSell-300,0032,601,922$46,626,442
Q1 2025Renaissance Technologies LLCBuy293,3002,702,814$48,434,427
Q4 2024Viking Global InvestorsBuy2,901,9252,901,925$50,551,534
Q4 2024Renaissance Technologies LLCBuy534,5002,409,514$41,973,734
Q3 2024Renaissance Technologies LLCSell-328,8001,875,014$26,231,446
Q2 2024Renaissance Technologies LLCSell-658,2002,203,814$18,115,351
Q1 2024Renaissance Technologies LLCSell-219,0002,862,014$22,066
Q4 2023Renaissance Technologies LLCBuy1,086,8923,081,014$27,698
Q3 2023Renaissance Technologies LLCBuy439,1091,994,122$17,827
Q2 2023Renaissance Technologies LLCSell-589,8091,555,013$23,885
Q1 2023Renaissance Technologies LLCBuy551,3002,144,822$48,237
Q4 2022Renaissance Technologies LLCBuy86,1001,593,522$33,512
Q3 2022Renaissance Technologies LLCSell-149,6001,507,422$37,143
Q2 2022Renaissance Technologies LLCBuy299,7001,657,022$40,150
Q1 2022Renaissance Technologies LLCBuy317,4001,357,322$34,978
Q4 2021Renaissance Technologies LLCSell-200,4961,039,922$32,279
Q3 2021Renaissance Technologies LLCSell-470,9041,240,418$30,080
Q2 2021Renaissance Technologies LLCBuy122,6001,711,322$24,968
Q1 2021Renaissance Technologies LLCSell-272,7001,588,722$39,670
Q4 2020Renaissance Technologies LLCBuy1,861,4221,861,422$50,733

Frequently asked questions about TVTX activity

  • Which institutional owners are buying TVTX?

    Institutional owners buying TVTX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in TVTX activity?

    "Buy" means an investor increased their reported position in TVTX compared to the prior reporting period. This reflects growing exposure to TRAVERE THERAPEUTICS INC (TVTX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in TVTX increasing?

    Institutional interest in TVTX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related TVTX Institutional Insights